新冠疫情紧急教训:为何世界需要常设协调的全球研发体系与可持续融资
该文基于近十年疫情应对经验,指出COVID-19期间疫苗、单抗和新型临床试验设计快速发展,但全球研发准备与响应生态系统仍存关键缺口,首要为全球融资体系,同时需改进使能科学与产品开发多环节,并呼吁立即行动。
要点
- COVID-19推动疫苗、单抗和新型试验设计在疫情开始一年内多国获批使用。
- 全球研发准备与响应生态系统的首要缺口是缺乏全球融资体系。
- 需改进使能科学与产品开发多环节的功能以提升研发效率。
核心结论
- 必须建立常设、协调的全球研发准备与响应生态系统并配套可持续融资。
- 当前应严肃解决全球融资体系等关键缺口。
研究设计与样本
- 本文为基于近期疫情经验与COVID-19应对实践的综述性分析。
主要发现
- COVID-19期间疫苗、单抗及新型临床试验设计快速发展,并在疫情开始一年内在多国获批使用。
- 全球研发准备与响应生态系统仍存多个必须弥合的缺口。
临床怎么用
- 推动建立常设协调的全球研发体系并完善可持续融资机制。
- 优先改进使能科学与产品开发各环节以提升响应速度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The research and development (R&D) ecosystem has evolved over the past decade to include pandemic infectious diseases, building on experience from multiple recent outbreaks. Outcomes of this evolution have been particularly evident during the COVID-19 pandemic with accelerated development of vaccines and monoclonal antibodies, as well as novel clinical trial designs. These products were developed, trialled, manufactured, and authorised for use in several countries within a year of the pandemic's onset. Many gaps remain, however, that must be bridged to establish a truly efficient and effective end-to-end R&D preparedness and response ecosystem. Foremost among them is a global financing system. In addition, important changes are required for multiple aspects of enabling sciences and product development. For each of these elements we identify priorities for improved and faster functionality. There will be no better time than now to seriously address these needs, however difficult, as the ravages of COVID-19 continue to accelerate with devastating health, social, and economic consequences for the entire community of nations.
引用
- Lurie N, Keusch GT, Dzau VJ, et al. Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development. Lancet. 2021. PMID: 33711296. doi:10.1016/S0140-6736(21)00503-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。